Kevin Gordon

Track

Insider profile

Currently holds positions in Veracyte Inc and Progyny Inc

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -21% 8.2% 15.1%
Success rate 9% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Veracyte Inc Dec. 12, 2016 -
Independent Director Progyny Inc None -
President, Chief Financial Officer Liquidia Technologies Inc None -
Chief Operating Officer, Executive Vice President IQVIA Holdings Inc Dec. 1, 2015 - Oct. 3, 2016
Chief Financial Officer, Executive Vice President IQVIA Holdings Inc July 1, 2010 - Dec. 1, 2015
Kevin Gordon's trades of Progyny Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-29 2026-05-27
US Progyny Inc (PGNY)
S Sale
50,537 +45.0%
422.97
US$3,628,564 		50,537 +45.0% 422.97 US$3,628,564
2026-05-27 2026-05-27
US Progyny Inc (PGNY)
PrS Proposed sale
48,161
233.20
US$3,705,944 		48,161 233.20 US$3,705,944
2025-08-13 2025-08-11
US Progyny Inc (PGNY)
S Sale
26,431 -5.5%
446.69
US$4,930,804 		26,431 -5.5% 446.69 US$4,930,804
2025-08-11 2025-08-11
US Progyny Inc (PGNY)
PrS Proposed sale
2,500
22.04
US$55,088 		2,500 22.04 US$55,088
2023-12-13 2023-12-11
US Progyny Inc (PGNY)
S Sale
2,500 -20.2%
35.93
US$89,825 		2,500 -20.2% 35.93 US$89,825
2023-12-11 2023-12-11
US Progyny Inc (PGNY)
PrS Proposed sale
2,500
35.93
US$89,826 		2,500 35.93 US$89,826
2023-05-26 2023-05-24
US Progyny Inc (PGNY)
S Sale
1,410 -10.2%
38.24
US$53,918 		1,410 -10.2% 38.24 US$53,918
2023-05-24 2023-05-24
US Progyny Inc (PGNY)
PrS Proposed sale
1,410
38.24
US$53,918 		1,410 38.24 US$53,918
2022-06-10 2022-06-08
US Veracyte Inc (VCYT)
S Sale
15,000 -63.2%
18.50
US$277,502 		15,000 -63.2% 18.50 US$277,502
2021-01-05 2021-01-04
US Veracyte Inc (VCYT)
PlS Planned sale
5,523 -100.0%
49.27
US$272,134 		5,523 -100.0% 49.27 US$272,134
2021-01-05 2021-01-04
US Veracyte Inc (VCYT)
PlS Planned sale
4,477 -44.8%
48.62
US$217,664 		4,477 -44.8% 48.62 US$217,664
2020-11-13 2020-11-12
US Veracyte Inc (VCYT)
PlS Planned sale
1,806 -100.0%
47.85
US$86,415 		1,806 -100.0% 47.85 US$86,415
2020-11-13 2020-11-12
US Veracyte Inc (VCYT)
PlS Planned sale
8,194 -81.9%
46.95
US$384,722 		8,194 -81.9% 46.95 US$384,722
2019-02-22 2019-02-22
PlS Planned sale
438 -0.3%
18.09
US$7,923 		438 -0.3% 18.09 US$7,923
2019-02-22 2019-02-22
PlS Planned sale
212 -0.1%
16.83
US$3,568 		212 -0.1% 16.83 US$3,568
2019-02-22 2019-02-22
PlS Planned sale
293 -0.2%
15.83
US$4,638 		293 -0.2% 15.83 US$4,638
2019-01-24 2019-01-22
PlS Planned sale
8,355 -4.9%
14.84
US$123,988 		8,355 -4.9% 14.84 US$123,988
2019-01-24 2019-01-22
PlS Planned sale
2,967 -1.7%
14.14
US$41,953 		2,967 -1.7% 14.14 US$41,953
2016-03-23 2016-03-22
PlS Planned sale
3,639 -16.9%
65.01
US$236,571 		3,639 -16.9% 65.01 US$236,571
2016-03-21 2016-03-18
PlS Planned sale
18,310 -50.6%
65.01
US$1,190,333 		18,310 -50.6% 65.01 US$1,190,333
2016-03-21 2016-03-17
PlS Planned sale
2,051 -10.3%
65.00
US$133,315 		2,051 -10.3% 65.00 US$133,315
2016-03-02 2016-03-01
PlS Planned sale
24,000 -57.3%
65.03
US$1,560,720 		24,000 -57.3% 65.03 US$1,560,720